The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Defining molecular determinants of sensitivity to EGFR inhibition in urothelial carinoma.
William Y. Kim
No relevant relationships to disclose
Tanja Hadzic
No relevant relationships to disclose
Samuel A. Heathcote
No relevant relationships to disclose
David T. Gammons
No relevant relationships to disclose
Kimryn Rathmell
No relevant relationships to disclose
Young E. Whang
No relevant relationships to disclose
Paul A. Godley
No relevant relationships to disclose
Matthew E. Nielsen
No relevant relationships to disclose
Eric Wallen
No relevant relationships to disclose
Raj Pruthi
No relevant relationships to disclose